About one out of every three American adults shows markers linked to metabolic risk, a scale that has changed research priorities. That reality makes reliable tools critical for lab teams studying obesity and type 2 diabetes. This page explains how a peptide-focused wellness brand provides an experimental, once-weekly triple-hormone agonist developed by Eli Lilly for…